Take Your Trading To The Next Level. Get Started Here!

Eli Lilly’s new diabetes drug continues to show promise as an obesity treatment

June 7, 2022 Comments Off

Eli Lilly continues to work on commercializing its strong innovation pipeline, which is a key reason the CNBC Investing Club owns the stock.